Skip to main content
Oria Health
The Journal

Deep Dives into Peptide Science

Research breakdowns, protocol design, and the latest findings from the world of peptide science. Written for researchers who care about the evidence.

Beyond Weight Loss: How Retatrutide Rewires Fat Metabolism at the Cellular Level
Research

Beyond Weight Loss: How Retatrutide Rewires Fat Metabolism at the Cellular Level

New metabolomics data from Eli Lilly reveals retatrutide doesn't just shrink fat. It transforms dysfunctional fat tissue into a metabolically healthy organ through enhanced fatty acid oxidation and insulin resistance reversal.

Jun 1, 2026Read more →
Retatrutide: The Triple Agonist That Makes Semaglutide Look Like a Warm-Up
Research

Retatrutide: The Triple Agonist That Makes Semaglutide Look Like a Warm-Up

Eli Lilly's retatrutide just delivered 24.2% body weight loss in 48 weeks — matching bariatric surgery. Three new May 2026 studies explain why hitting three hormone receptors simultaneously changes everything.

May 23, 2026Read more →
GHK-Cu: The Copper Peptide That Modulates 25% of Your Genome
Research

GHK-Cu: The Copper Peptide That Modulates 25% of Your Genome

GHK-Cu isn't just a skincare ingredient. Genomic analysis shows it modulates over 4,000 human genes — and the research is exploding.

May 6, 2026Read more →
Peptides in Orthopaedics: What the 2026 AAOS Review Reveals
Research

Peptides in Orthopaedics: What the 2026 AAOS Review Reveals

The American Academy of Orthopaedic Surgeons just published a comprehensive review on BPC-157, TB-500, and GHK-Cu. Here's what the evidence actually shows about peptides for injury recovery.

May 3, 2026Read more →
BLMP6: The Peptide That Hunts Down Metastatic Breast Cancer Cells
Research

BLMP6: The Peptide That Hunts Down Metastatic Breast Cancer Cells

UTHealth Houston researchers engineered a peptide that targets fibulin-4 on metastatic breast cancer cells, dramatically suppressing tumors in mice. Here's how it works and why it matters.

May 1, 2026Read more →
CJC-1295/Ipamorelin and Sleep Problems: Why It Happens and How to Fix It
Research

CJC-1295/Ipamorelin and Sleep Problems: Why It Happens and How to Fix It

Started CJC-1295/Ipamorelin and now you can't sleep? You're not alone. Here's why GH secretagogues disrupt sleep and what actually works to fix it.

Apr 30, 2026Read more →
The GLP-1 Pill Wars Have Begun. Here's What Actually Changed.
Research

The GLP-1 Pill Wars Have Begun. Here's What Actually Changed.

Eli Lilly's Foundayo just became the first GLP-1 pill you can take without food restrictions. Novo Nordisk's oral semaglutide is heading to teenagers. The injection era is ending — but the details matter.

Apr 25, 2026Read more →
The Drug Quietly Revolutionizing 6 Areas of Medicine (And It's Not About Weight)
Research

The Drug Quietly Revolutionizing 6 Areas of Medicine (And It's Not About Weight)

Everyone knows Ozempic for weight loss. But semaglutide is being studied for Alzheimer's, heart disease, liver failure, addiction, and chronic inflammation — and the data is extraordinary.

Apr 22, 2026Read more →
Why Smart Researchers Stack Peptides: The Science of Synergy
Research

Why Smart Researchers Stack Peptides: The Science of Synergy

BPC-157 + TB-500. Ipamorelin + CJC-1295. Semax + Selank. The most effective peptide protocols aren't single compounds — they're carefully designed combinations. Here's the science behind why.

Apr 20, 2026Read more →